Two men，seated indoors around a table，engaged ina conversation and playing chess

发现频率

Our innovative medicines address society’s greatest disease burdens and restore possibility for patients。
钢轨伸缩装置

展开，展开

Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives。
组，组，组，组，组，组，组，组，组，组

左下倾斜，左下倾斜

Creating a medicine is just the beginning of the journey.Discover how we embrace societal impact as a core business objective。
三维Illustration of molecules

2024 ASCO Annual Meeting

Novartis is at the 2024ASCO Annual Meeting from May31 to June42024。

Learn more

Latest news

主312024

  • 介质更新

Novartis NATALEE study shows Kisqali®reduces risk of cancer recurrence for early breast cancer patients with high-risk node-negative disease

主312024

  • 介质释放，介质释放

Novartis Scemblix®Phase III data first to show superior efficicacy with a favorable safety and tolerability简介vs.standard-of-care TKIs in adults with newly diagnosed CML

主312024

  • 介质释放，介质释放

Novartis Phase III data confirm sustained efficy and long-term safety of oral remibrutinib in chronic spontaneous urticaria
全部，全部

The burden of IgAN

IgAN nephropathy（IgAN）is a heterogeneous，progressive，rare kidney disease and is a major cause of chronic kidney disease worldwide.Novartis is working to slow the progression of this disease and extend a dialysis-free life in patients。

Learn more
Shanelle Gabriel spending time with her father in New York

Novartis in Society Integrated Report2023

Learn about our business，strategy and performance in2023，and how we create sustainable value for stakeholders and society。

查看online summary
Two business people laughing

Welcome to where we thrive together

Working together.Learning together.Thriving together.Discover how you can join us in changing people's lives。

Join us

资源链接

About Novartis
Healthcare professionals
Patients and caregivers
Pipeline
产品，产品